WR-mAb1

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameWR-mAb1

Drug Alias NamePD-1 checkpoint inhibitor (Transgene)anti-PD-1 oncolytic monoclonal antibody (Transgene)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionProgrammed cell death protein 1 blockers

TargetsProgrammed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTransgene Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTransgene Sa

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A